Synthesis, characterization and antitumor activity of palladium(II) complexes of monoethyl 8-quinolylmethylphosphonate

Polyhedron

Volumn 27, Issue 4, 2008, Pages 1317-1328

  Tušek Božić, Ljerka ^a   Juribašić, Marina ^a   Traldi, Pietro ^b   Scarcia, Vito ^c   Furlani, Ariella ^c  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Antitumor activity; Palladium(II) complex; Quinolylmethylphosphonate complex; Spectroscopy

Indexed keywords

BIOACTIVITY; CELL CULTURE; CHELATION; IONS; NUCLEAR MAGNETIC RESONANCE; ORGANIC ACIDS; PALLADIUM COMPOUNDS; SALTS; SPECTROSCOPIC ANALYSIS; SYNTHESIS (CHEMICAL); THERMOANALYSIS;

ACIDIC SOLUTIONS; ANTITUMOUR ACTIVITY; FORMING PROPERTIES; HALIDE COMPOUNDS; MONOESTERS; PALLADIUM(II) COMPLEX; PHOSPHONIC ACIDS; QUINOLYLMETHYLPHOSPHONATE COMPLEX; SODIUM SALT; WIDE PH RANGE;

LIGANDS;

EID: 39649085120     PISSN: 02775387     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.poly.2008.01.002     Document Type: Article

References (61)

1. O'Dwyer P.J., Stevenson P., and Johnson S.W. Clinical status of cisplatin, carboplatin, and other platinum-based antitumor drugs. In: Lippert B. (Ed). Chemistry and Biochemistry of a Leading Anticancer Drug (1999), Verlag Helvetica Chimica Acta, Zurich 31-72
2. Sava G., Alessio E., Bergamo A., and Mestroni G. Sulphoxide ruthenium complexes: non-toxic tools for the selective treatment of solid tumour metastases. In: Clarke M.J., and Sadler P.J. (Eds). Topics in Biological Inorganic Chemistry-Metallopharmaceuticals I (1999), Springer, Berlin 143-169
3. Groessl M., Reisner E., Hartinger C.G., Eichinger R., Semenova O., Timerbaev A.R., Jakupec M.A., Arion V.B., and Keppler B.K. J. Med. Chem. 50 (2007) 2185
4. Yan Y.K., Melchart M., Habtemariam A., and Sadler P.J. Chem. Commun. (2005) 4764
5. Liu H.-K., Berners-Price S.J., Wang F., Parkinson J.A., Xu J., Bella J., and Sadler P.J. Angew. Chem., Int. Ed. 45 (2006) 8153
6. Gill D.S. In: Hacker M.P., Douplr E.B., and Krakoff I.H. (Eds). Platinum Coordination Complexes in Cancer Chemotherapy (1984), Nijhoff, Boston 267-278
7. Hollis L.S. In: Howell S.B. (Ed). Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (1991), Plenum Press, New York 115-125
8. Wimmer F.L., Wimmer S., Castan P., Cros S., Johnson N., and Colacio-Rodrigez E. Anticancer Res. 9 (1989) 791
9. Higgins III J.D., Neely L., and Fricker S. J. Inorg. Biochem. 49 (1993) 149
10. Kovala-Demertzi D., Demertzis M.A., Filiou E., Pantazaki A.A., Yadav P.N., Miller J.R., Zheng Y., and Kyriakidis D.A. Biometals 16 (2003) 411
11. Budizisz E., Krajewska U., Rozalski M., Szulawska A., Czyz M., and Nawrot B. Eur. J. Pharmacol. 502 (2004) 59
12. Kuduk-Jaworska J., Puszko A., Kibiak M., and Pelczynska M. J. Inorg. Biochem. 98 (2004) 1447
13. Zhao G., and Lin H. Curr. Med. Chem. - Anticancer Agents 5 (2005) 137
14. Kovala-Demertzi D., Bocarelli A., Demertzis M.A., and Coluccia M. Chemotherapy 53 (2007) 148
15. Tušek-Božić Lj., Matijašić I., Bocelli G., Calestani G., Furlani A., Scarcia V., and Papaioannou A. J. Chem. Soc., Dalton Trans. (1991) 195
16. Tušek-Božić Lj., Komac M., Ćurić M., Lyčka A., D'Alpaos M., Scarcia V., and Furlani A. Polyhedron 19 (2000) 937
17. Tušek-Božić Lj., Cmrečki V., Balzarini J., and De Clercq E. Lett. Drug Des. Discov. 3 (2006) 528
18. Tušek-Božić Lj., Matijašić I., Bocelli G., Sgarabotto G., Furlani A., Scarcia V., and Papaioannou A. Inorg. Chim. Acta 185 (1991) 229
19. Tušek-Božić Lj., Furlani A., Scarcia V., De Clercq E., and Balzarini J. J. Inorg. Biochem. 72 (1998) 201
20. Kafarski P., and Lejczak B. In: Kukhar V.P., and Hudson H.R. (Eds). Aminophosphonic and Aminophosphinic Acids. Chemistry and Biological Activity (2000), John Wiley & Sons, Chichester 407-442
21. Atherton F.R., Hassall C.H., and Lambert R.W. J. Med. Chem. 29 (1986) 29
22. Du S., Faiger H., Belakhov V., and Baasov T. Bioorg. Med. Chem. 7 (1999) 2671
23. Klenner T., Valenzuela-Paz P., Amelung F., Münch H., Zahn H., Keppler B.K., and Blum H. Platinum phosphonato complexes with particular activity against bone malignancies. An evaluation of an experimental model highly predictive for the clinical situation. In: Keppler B.K. (Ed). Metal Complexes in Cancer Chemotherapy (1993), VCH, Weinheim 85-127
24. Brzezinska-Blaszczyk E., Mincikiewicz M., and Ochocki J. Eur. J. Pharmacol. 298 (1996) 155
25. Bloemink M.J., Diederen J.H., Dorenbos J.P., Heeterbij R.J., Keppler B.K., and Reedijk J. Eur. J. Inorg. Chem. 10 (1999) 1655
26. Ćurić M., Tušek-Božić Lj., Vikić-Topić D., Scarcia V., Furlani A., Balzarini J., and De Clercq E. J. Inorg. Biochem. 63 (1996) 125
27. Tušek-Božić Lj., Frausin F., Scarcia V., and Furlani A. J. Inorg. Biochem. 95 (2003) 259
28. Jagodić V., Božić B., Tušek-Božić Lj., and Herak M.J. J. Heterocycl. Chem. 17 (1980) 685
29. Tallarida R.J., and Murray R.B. Manual of Pharmacological Calculations with Computer Programs (1987), Springer, New York
30. Tušek-Božić Lj., and Lyčka A. Magn. Reson. Chem. 40 (2002) 175
31. Višnjevac A., and Tušek-Božić Lj. Acta Crystallogr. C60 (2004) o434
32. Jagodić V., and Tušek Lj. J. Org. Chem. 37 (1972) 1222
33. Tušek-Božić Lj. Vib. Spectrosc. 28 (2002) 235
34. Tušek-Božić Lj., and D'Alpaos M. Polyhedron 17 (1998) 1481
35. Appleton T.G., Hall J.R., and McMahon I.J. Inorg. Chem. 25 (1986) 720
36. Galdecki Z., and Wolf W.M. Acta Crystallogr. C46 (1990) 271
37. Ochocki J., Kostka K., Zurowska B., Mrozinski J., Galdecka E., Galdecki Z., and Reedijk J. J. Chem. Soc., Dalton Trans. (1992) 2955
38. Fernandez D., and Vega D. Acta Crystallogr. C59 (2003) o228
39. Fernandez D., Vega D., and Ellena J.A. Acta Crystallogr. C59 (2003) o289
40. I. Matijašić, G. Bocelli, Lj. Tušek-Božić, in: Third Slovenian-Croatian-Crystallographic Meeting, Kranjska gora, Slovenia, 1994, p. 20.
41. Silverstein R.M., and Webster F.X. Spectrometric Identification of Organic Compounds. 6th ed. (1998), John Wiley & Sons, New York
42. Thomas L.C. Interpretation of Infrared Spectra of Organophosphorus Compounds (1974), Plenum Press, New York pp. 39-45
43. Herlinger A.W., Ferraro J.R., Chiarizia R., and Horwitz E.P. Polyhedron 16 (1997) 1843
44. Nakamoto K. Infrared and Raman Spectra of Inorganic and Coordination Compounds, Part B: Applications in Coordination Organometallic and Bioinorganic Chemistry. 5th ed. (1997), Wiley-Interscience
45. Moreno-Vida M.I., Colacio-Rodrigues E., Moreno-Carretero M.N., Salas-Peregrin J., Simard M., and Beauchamp A.L. Inorg. Chim. Acta 157 (1989) 201
46. Albinati A., Pregosin P.S., and Wombacher F. Inorg. Chem. 29 (1990) 1812
47. Stang P.J., Olenyuk B., and Arif A.M. Organometallics 14 (1995) 5281
48. Bierbach U., and Farrell N. Inorg. Chem. 36 (1997) 3657
49. Scolaro R.M., Mazzaglia A., Romeo A., Plutino M.R., Castriciano M., and Romeo R. Inorg. Chim. Acta 330 (2002) 189
50. Livingstone S.E. The Chemistry of Ruthenium, Rhodium, Palladium, Osmium, Iridium and Platinum (1973), Pergamon Press, Oxford
51. Onyang J., Tai Z., Jiang C., and Tang W. Spectrosc. Lett. 29 (1996) 763
52. Sola J., and Yanez R. J. Chem. Soc., Dalton Trans. (1986) 2021
53. McLafferty F.W. Interpretation of Mass Spectra. 3rd ed. (1980), University Science Books, CA p. 65
54. Caliceti P., Veronese F.M., Marsilio F., Lora S., Seraglia R., and Traldi P. Org. Mass Spectrom. 27 (1992) 1199
55. Harden C.S., Snyder A.P., and Eiceman G.A. Org. Mass Spectrom. 28 (1993) 585
56. De Hoffmann E., and Stroobant V. Mass Spectrometry, Principles and Applications. 2nd ed. (2002), John Wiley & Sons Ltd., Baffins Lane, Chichester
57. Perleps S.P., Jacops P., Desseyn H.O., and Tsangaris J.M. Spectrochim. Acta 43A (1987) 771
58. In: Lide D.R. (Ed). Handbook of Chemistry and Physics (1998-1999), The Chemical Rubber Co., Boca Raton, Florida 76
59. Souchard J.P., Ha T.T.B., Cros S., and Johnson N.P. J. Med. Chem. 34 (1991) 863
60. Reedijk J. Chem. Commun. (1996) 801
61. Lee Y.A., Chung Y.K., and Sohn Y.S. J. Inorg. Biochem. 68 (1997) 289